Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Amit Indubhushan Bakshi
Full-time employees:3548
City:Ahmedabad
Address:Shivarth Ambit
IPO:2017-06-30
CIK:
Website:
General Outlook
In simple terms, Eris Lifesciences Limited has 136.047 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.818% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.266%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.210%. This tells us they're good at keeping money after all costs.
Return on Investments
Eris Lifesciences Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.167%.
Stock Prices
Eris Lifesciences Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $854.9, while its low point bottomed out at $843.9. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Eris Lifesciences Limited's stock market.
Profitability Ratios
ERIS.NS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 23.39% underscores its earnings before tax deductions.
The effective tax rate stands at 11.98%, revealing its tax efficiency.
The net income per EBT, 89.77%, and the EBT per EBIT, 87.83%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 26.63%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
23.39%
Effective Tax Rate
11.98%
Net Income per EBT
89.77%
EBT per EBIT
87.83%
EBIT per Revenue
26.63%
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 19.15, and free cash flow per share, 19.15, depict cash generation on a per-share basis.
The cash per share value, 14.01, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.14, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
19.15
Free Cash Flow per Share
19.15
Cash per Share
14.01
Operating Cash Flow Sales Ratio
0.14
Free Cash Flow to Operating Cash Flow Ratio
1.00
Debt and Leverage Ratios
An interest coverage of 8.08 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Interest Coverage
8.08
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.20%, indicates top-line expansion, while the gross profit growth, 12.05%, reveals profitability trends.
EBIT growth, 10.42%, and operating income growth, 10.42%, offer insights into operational profitability progression.
The net income growth, -5.90%, showcases bottom-line expansion, and the EPS growth, 14.26%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
11.20%
Gross Profit Growth
12.05%
EBIT Growth
10.42%
Operating Income Growth
10.42%
Net Income Growth
-5.90%
EPS Growth
14.26%
EPS Diluted Growth
14.31%
Weighted Average Shares Growth
0.07%
Weighted Average Shares Diluted Growth
0.02%
Dividends per Share Growth
9.22%
Operating Cash Flow Growth
0.77%
Free Cash Flow Growth
-26.42%
10-Year Revenue Growth per Share
241.43%
5-Year Revenue Growth per Share
56.85%
3-Year Revenue Growth per Share
38.78%
10-Year Operating CF Growth per Share
906.95%
5-Year Operating CF Growth per Share
63.14%
3-Year Operating CF Growth per Share
71.68%
10-Year Net Income Growth per Share
564.51%
5-Year Net Income Growth per Share
31.50%
3-Year Net Income Growth per Share
30.45%
10-Year Shareholders Equity Growth per Share
1720.39%
5-Year Shareholders Equity Growth per Share
124.21%
3-Year Shareholders Equity Growth per Share
67.88%
3-Year Dividend per Share Growth per Share
75.85%
Receivables Growth
-0.86%
Inventory Growth
24.82%
Asset Growth
23.84%
Book Value per Share Growth
20.97%
Debt Growth
1145.49%
R&D Expense Growth
542.93%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.75, and the price to book ratio, 4.75, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 6.27, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 44.29, and price to operating cash flows, 44.28, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
4.75
Price to Book Ratio
4.75
Price to Sales Ratio
6.27
Price Cash Flow Ratio
44.28
Price Earnings to Growth Ratio
2.09
Enterprise Value Multiple
17.33
Price Fair Value
4.75
Price to Operating Cash Flow Ratio
44.28
Price to Free Cash Flows Ratio
44.29
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
